REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 181 filers reported holding REGENXBIO INC in Q3 2021. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,538,316 | -10.6% | 883,146 | +8.6% | 0.00% | 0.0% |
Q2 2023 | $16,262,451 | +13.0% | 813,529 | +6.9% | 0.00% | 0.0% |
Q1 2023 | $14,386,677 | +86415.6% | 760,797 | +3.8% | 0.00% | 0.0% |
Q4 2022 | $16,629 | -99.9% | 733,245 | +3.6% | 0.00% | -33.3% |
Q3 2022 | $18,701,000 | +8.2% | 707,573 | +1.1% | 0.00% | 0.0% |
Q2 2022 | $17,284,000 | -24.0% | 699,768 | +2.1% | 0.00% | 0.0% |
Q1 2022 | $22,756,000 | +4.2% | 685,639 | +2.7% | 0.00% | 0.0% |
Q4 2021 | $21,838,000 | -21.7% | 667,853 | +0.4% | 0.00% | -25.0% |
Q3 2021 | $27,894,000 | +8.3% | 665,419 | +0.4% | 0.00% | 0.0% |
Q2 2021 | $25,746,000 | +20.2% | 662,708 | +5.5% | 0.00% | +33.3% |
Q1 2021 | $21,418,000 | -9.7% | 627,937 | +20.0% | 0.00% | -25.0% |
Q4 2020 | $23,731,000 | +74.8% | 523,188 | +6.0% | 0.00% | +33.3% |
Q3 2020 | $13,578,000 | -27.8% | 493,396 | -3.4% | 0.00% | -25.0% |
Q2 2020 | $18,808,000 | +18.5% | 510,678 | +4.2% | 0.00% | 0.0% |
Q1 2020 | $15,872,000 | -58.0% | 490,210 | -46.9% | 0.00% | 0.0% |
Q4 2019 | $37,792,000 | +131.7% | 922,444 | +101.4% | 0.00% | 0.0% |
Q3 2019 | $16,308,000 | -26.6% | 458,093 | +6.0% | 0.00% | -20.0% |
Q2 2019 | $22,206,000 | -4.9% | 432,291 | +6.1% | 0.01% | -16.7% |
Q1 2019 | $23,346,000 | -26.5% | 407,374 | -46.2% | 0.01% | +20.0% |
Q4 2018 | $31,778,000 | +24.3% | 757,576 | +123.7% | 0.01% | -28.6% |
Q3 2018 | $25,566,000 | +19.9% | 338,629 | +14.0% | 0.01% | 0.0% |
Q2 2018 | $21,321,000 | +174.3% | 297,167 | +14.1% | 0.01% | +133.3% |
Q1 2018 | $7,773,000 | -5.9% | 260,412 | +4.9% | 0.00% | 0.0% |
Q4 2017 | $8,256,000 | +1.9% | 248,328 | +1.0% | 0.00% | 0.0% |
Q3 2017 | $8,099,000 | +78.4% | 245,822 | +6.9% | 0.00% | +50.0% |
Q2 2017 | $4,540,000 | +37.3% | 229,907 | +34.2% | 0.00% | +100.0% |
Q1 2017 | $3,306,000 | +7.8% | 171,346 | +3.6% | 0.00% | 0.0% |
Q4 2016 | $3,068,000 | +36.3% | 165,397 | +2.9% | 0.00% | 0.0% |
Q3 2016 | $2,251,000 | +299.1% | 160,729 | +127.8% | 0.00% | – |
Q2 2016 | $564,000 | -8.6% | 70,571 | +23.5% | 0.00% | – |
Q1 2016 | $617,000 | -23.9% | 57,142 | +16.9% | 0.00% | – |
Q4 2015 | $811,000 | – | 48,887 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |